Skip to main content

Day: June 1, 2022

Forbes Names FTI Consulting #1 Professional Services Firm for New Graduates

WASHINGTON, June 01, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) was named the leading professional services firm on Forbes magazine’s 2022 list of America’s Best Employers for New Graduates. Among the 300 employers recognized on the list, FTI Consulting was ranked first among professional services firms and #32 overall among companies in the United States. Commenting on the recognition, Holly Paul, Chief Human Resources Officer at FTI Consulting, said, “At FTI Consulting, we encourage young professionals to become the next generation of leaders by honing their skills and developing their expertise in an environment that provides the support and resources necessary to thrive in their careers. Being named the number one professional services firm for new graduates reflects our commitment to attracting, developing and...

Continue reading

Laurentian Bank of Canada reports second quarter 2022 results

The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April 30, 2022, and has been prepared in accordance with International Financial Reporting standards (IFRS), as issued by the International Accounting Standards Board (IASB). All amounts are denominated in Canadian dollars. The Laurentian Bank of Canada and its entities are collectively referred to as “Laurentian Bank” or the “Bank” and provide deposit, investment, loan, securities, trust and other products or services.MONTREAL, June 01, 2022 (GLOBE NEWSWIRE) — Laurentian Bank of Canada reported net income of $59.5 million and diluted earnings per share of $1.34 for the second quarter of 2022, compared with $53.1 million and $1.15 for the second quarter of 2021. Return on common...

Continue reading

Inozyme Pharma to Present at the 2022 Jefferies Healthcare Conference

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will present at the Jefferies Healthcare Conference. The presentation will take place on Wednesday, June 8, 2022 at 2:30 PM ET. A replay of the presentation can be accessed from the Investor Relations section of Inozyme’s website and will be available for a limited time following the events. About Inozyme Pharma Inozyme Pharma, Inc. (Nasdaq: INZY) is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft...

Continue reading

Collective Mining Outlines Multiple, High-Grade Vein Systems at Olympus with Assay Results from Channel Sampling of up to 137 g/t Gold and 563 g/t Silver

Figure 1 Plan View of the Guayabales Project Highlighting the Olympus TargetFigure 2 Olympus Target, Measuring 1.4 Kilometres x 0.9 Kilometres and OpenFigure 3: Photos of High-Grade Polymetallic Grab Samples Taken at Olympus Veins of massive sulfides with pyrite, sphalerite, galena and chalcopyrite.TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — Collective Mining Ltd. (TSXV: CNL) (“Collective” or the “Company”) is pleased to announce high-grade gold and silver channel sample assay results from its grassroots generated Olympus target (“Olympus”) located within the Guayabales project (“Guayabales”), Colombia. Olympus is centrally situated within the four-by-four kilometre porphyry cluster where to date, the Company has generated eight drill targets through grassroots prospecting. Four of these targets have been drill tested yielding...

Continue reading

CHAR Technologies Appoints Chief Commercial Officer

TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — CHAR Technologies Ltd. (“CHAR Technologies” or the “Company”) (TSX Venture Exchange: YES) announces the appointment of Mr. Lewis Smith to the position of Chief Commercial Officer (CCO) effective June 1, 2022. Mr. Smith will be responsible for the growth of the Company’s High Temperature Pyrolysis (HTP) business, including development of HTP projects across North America and maximizing the value received for HTP project outputs, including renewable natural gas, green hydrogen and biocarbon. Mr. Smith has more than 25 years of experience with the clean energy and technology sectors, with recent roles that include Chief Strategy Officer & General Counsel at Modus Workflow, Chief Corporate Development Officer at GoGreen Communications Inc. and General Counsel at Emera. Chief...

Continue reading

Zumiez Announces Participation in the William Blair 42nd Annual Growth Stock Conference

LYNNWOOD, Wash., June 01, 2022 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women, today announced that management will participate in the William Blair 42nd Annual Growth Stock Conference. The presentation is scheduled for Tuesday, June 7, 2022 at 10:00 am Central Time. The live webcast can be accessed via the investor relations page of Zumiez website at http://ir.zumiez.com. About Zumiez Inc. Zumiez is a leading specialty retailer of apparel, footwear, accessories and hardgoods for young men and women who want to express their individuality through the fashion, music, art and culture of action sports, streetwear, and other unique lifestyles. As of May 28, 2022, we operated 741 stores, including 601 in the United States, 52 in Canada,...

Continue reading

Aehr Test Systems Confirms Financial Guidance of Revenues Exceeding $50 Million for Fiscal Year Ending May 31, 2022 Ahead of Craig-Hallum Institutional Investor Conference

FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today confirms its previously provided financial guidance ahead of hosting virtual meetings with investors today at the 19th Annual Craig-Hallum Institutional Investor Conference. For its fiscal year ended May 31, 2022, Aehr completed full year total revenue of greater than $50 million, with strong profit growth in line with its operating model. Aehr Test President and CEO Gayn Erickson commented, “We are pleased to have finished a strong year yesterday, with fiscal year 2022 total annual revenue of greater than $50 million, more than three times last year’s revenue, and healthy profitability. “We continue to be excited about the silicon carbide market for electric...

Continue reading

Arrival Van Completes All Type Approval Testing

LUXEMBOURG, June 01, 2022 (GLOBE NEWSWIRE) — Arrival (NASDAQ: ARVL), inventor of a unique new method of design and production of equitable electric vehicles (EVs) by local Microfactories, today announced that physical type approval testing is now complete for the Van, and Arrival expects to receive official paperwork over the coming weeks for European Whole Vehicle Type Approval (EUWVTA). “This is another milestone achievement for Arrival following the recent certification of our Bus, and is a testimony to our innovative technologies and our unique new method of design and production of electric vehicles. We are excited to see our customers start to operate our vehicles later this year,” said Denis Sverdlov, Founder and CEO at Arrival. Arrival expects to receive official paperwork over the coming weeks for the European...

Continue reading

Draganfly Announces New Heavy Lift and High-Endurance Multi-Use Drones

Los Angeles, CA., June 01, 2022 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce the launch of its new North American-made Heavy Lift and Commander 3 XL Drones. Draganfly’s Heavy Lift Drone is a versatile, industrial, multirotor unmanned aerial vehicle (“UAV”) that is designed to lift more and fly further. Capable of automated missions and manual flight operations, the Company’s heavy-duty, robust UAV has a payload lift capacity of 67 pounds and up to 55 minutes of flight time. Draganfly’s Commander 3 XL Drone is a high-endurance, weather-resistant, multirotor UAV that is designed for easy assembly and rapid deployment. The “Swiss Army Knife” of drones is capable of drop and winch-down...

Continue reading

Annexon Biosciences to Present Data Highlighting Novel Approach to Treating Complement-Driven Diseases at Upcoming Medical Meetings

BRISBANE, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that the company will present data from across its complement-targeted pipeline at several upcoming medical meetings. “Our platform approach at Annexon is based on our founding thesis that by inhibiting C1q and the entire classical complement cascade, we could develop medicines that potentially provide more complete protection against the negative upstream and downstream impacts of the classical pathway,” said Ted Yednock, Ph.D., executive vice president and chief innovation officer of Annexon. “We are excited to be showcasing data from several...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.